Eli Lilly

Lilly's tirzepatide beats Novo's semaglutide in diabetes phase 3, but another study muddies picture
Lilly's tirzepatide beats Novo's semaglutide in diabetes phase 3, but another study muddies picture
Fierce Biotech
Eli Lilly
Novo Nordisk
tirzepatide
semaglutide
type 2 diabetes
clinical trials
Flag link:
Eli Lilly, Incyte Report Positive Results For Baricitinib In Alopecia Areata Treatment
Eli Lilly, Incyte Report Positive Results For Baricitinib In Alopecia Areata Treatment
NASDAQ
Eli Lilly
Incyte
baricitinib
alopecia areata
Flag link:
Look for Eli Lilly's Verzenio to hit $4.6B, thanks to early breast cancer win: analyst
Look for Eli Lilly's Verzenio to hit $4.6B, thanks to early breast cancer win: analyst
Fierce Pharma
Eli Lilly
Verzenio
breast cancer
early breast cancer
Flag link:
Lilly scores $210M supply deal for newly authorized coronavirus antibody cocktail
Lilly scores $210M supply deal for newly authorized coronavirus antibody cocktail
Fierce Pharma
Eli Lilly
antibodies
COVID-19
government contract
Flag link:
Merck inks $1.9B Pandion takeover to square up against Amgen, Lilly and Roche
Merck inks $1.9B Pandion takeover to square up against Amgen, Lilly and Roche
Fierce Biotech
Merck
Pandion
M&A
immune modulators
Amgen
Eli Lilly
Roche
Flag link:
Watch out, Novo Nordisk. Lilly's new dual action diabetes med could pressure Ozempic: analyst
Watch out, Novo Nordisk. Lilly's new dual action diabetes med could pressure Ozempic: analyst
Fierce Pharma
Eli Lilly
tirzepatide
Novo Nordisk
Ozempic
diabetes
Flag link:
Eli Lilly's David Ricks snared $24M pay package in a year turbo-boosted by Covid-19 antibody
Eli Lilly's David Ricks snared $24M pay package in a year turbo-boosted by Covid-19 antibody
Endpoints
Eli Lilly
David Ricks
executive pay
Pharma CEOs
pandemic
COVID-19
Flag link:
Lilly wagers almost $1B on Rigel's drugs for immune and nervous systems
Lilly wagers almost $1B on Rigel's drugs for immune and nervous systems
BioPharma Dive
Eli Lilly
Rigel Pharmaceuticals
autoimmune disease
inflammatory disease
Flag link:
Lilly's tirzepatide aces 2 more late-phase diabetes trials
Lilly's tirzepatide aces 2 more late-phase diabetes trials
Fierce Biotech
Eli Lilly
tirzepatide
type 2 diabetes
clinical trials
Flag link:
Ousted Eli Lilly CFO Loses $24 Million in Potential Pay
Ousted Eli Lilly CFO Loses $24 Million in Potential Pay
BioSpace
Eli Lilly
Josh Smiley
executive pay
Flag link:
Eli Lilly scores FDA nod for COVID-19 antibody cocktail, aims to make 1M doses by midyear
Eli Lilly scores FDA nod for COVID-19 antibody cocktail, aims to make 1M doses by midyear
Fierce Pharma
Eli Lilly
COVID-19
antibodies
FDA
Emergency Use Authorization
Flag link:
Eli Lilly's chief financial officer resigned after a misconduct investigation revealed he sent 'consensual though inappropriate' personal messages to employees
Eli Lilly's chief financial officer resigned after a misconduct investigation revealed he sent 'consensual though inappropriate' personal messages to employees
Business Insider
Eli Lilly
inappropriate conduct
Flag link:
Lilly cancer R&D chief Bilenker quits, handing reins to deputy
Lilly cancer R&D chief Bilenker quits, handing reins to deputy
Fierce Biotech
Eli Lilly
R&D
Josh Bilenker
Loxo Oncology
Flag link:
Eli Lilly stock dipped Friday despite reporting better-than-expected fourth-quarter estimates on strong sales of diabetes and cancer drugs
Eli Lilly stock dipped Friday despite reporting better-than-expected fourth-quarter estimates on strong sales of diabetes and cancer drugs
Investors Business Daily
Eli Lilly
earnings
Flag link:
Lilly lands clinical-phase pain drug via deal with Asahi Kasei
Lilly lands clinical-phase pain drug via deal with Asahi Kasei
Fierce Biotech
Eli Lilly
Asahi Kasei
neuroinflammatory pain
Flag link:
Lilly amps Type 1 diabetes partnerships to reach more young people
Lilly amps Type 1 diabetes partnerships to reach more young people
Fierce Pharma
Eli Lilly
pharma marketing
type 1 diabetes
Flag link:
Regeneron COVID-19 drug cocktail combats South Africa variant, Lilly's does not - study
Regeneron COVID-19 drug cocktail combats South Africa variant, Lilly's does not - study
Reuters
Regeneron
Eli Lilly
antibodies
COVID-19
Flag link:
Vir and GSK Team Up with Eli Lilly for Double Monoclonal Antibody Study
Vir and GSK Team Up with Eli Lilly for Double Monoclonal Antibody Study
BioSpace
Vir Biotechnology
Eli Lilly
GSK
VIR-7831
bamlanivimab
COVID-19
Flag link:
Lilly antibody combo slashed COVID-19 deaths, hospitalizations in high-risk patients
Lilly antibody combo slashed COVID-19 deaths, hospitalizations in high-risk patients
Fierce Pharma
Eli Lilly
antibodies
COVID-19
Flag link:
3 Blockbuster Drug Launches to Watch This Year
3 Blockbuster Drug Launches to Watch This Year
Motley Fool
drug launches
GSK
Cabenuva
HIV
ViiV
Gilead Sciences
Trodelvy
Eli Lilly
Retevmo
cancer
Flag link:

Pages